Clinical observation of Qianlie Shutong Capsules combined with finasteride in treatment of benign prostatic hyperplasia
Bin SHI,Kun CHEN,Zhi-ming ZHANG,Fei CHEN,Xue-song YANG
DOI: https://doi.org/10.7501/j.issn.1674-5515.2016.04.022
2016-01-01
Abstract:Objective To explore the clinical efficacy of Qianlie Shutong Capsules combined with finasteride in treatment of benign prostatic hyperplasia. Methods Patients (88 cases) with benign prostatic hyperplasia in Department of Urinary Surgery of Shifang People’s Hospital from August 2014 to August 2015 were randomly divided into control and treatment groups. Each group had 44 cases. The patients in the control group were po administered with Finasteride Tablets, 5 mg/time, once daily. The patients in the treatment group were po administered with Qianlie Shutong Capsules on the basis of the control group, 3 grains/time, three times daily. The patients in two groups were treated for eight weeks. After treatment, the efficacy was evaluated, and the changes of IPSS scores, PV, RV, and Qmax in two groups were compared. Results After treatment, the efficacies in the control and treatment groups were 88.64% and 95.45%, respectively, and there were differences between two groups (P < 0.05). After treatment, IPSS scores, PV, and RV were significantly decreased, and Qmax was significantly increased, and the difference was statistically significant in the same group (P < 0.05). After treatment, the observational indexes in the treatment group were significantly better than those in the control group, with significant difference between two groups (P < 0.05). Conclusion Qianlie Shutong Capsules combined with finasteride has clinical curative effect in treatment of benign prostatic hyperplasia, and can significantly improve the clinical symptoms, and reduce the RV and PV, which has a certain clinical application value.